U.S. Food and Drug Administration (USFDA) has completed audit at FDC’s manufacturing facility located at Baddi, Himachal Pradesh which is dedicated for manufacturing Cephalosporin Oral dosage forms with No observations (Zero 483’s).
FDC is among India’s leading fully integrated pharmaceutical companies.